Verano Holdings (VRNO) Capital Expenditures (2021 - 2026)
Verano Holdings (VRNO) reported Capital Expenditures of $14.9 million for Q1 2026, up 7.74% year-over-year from $13.9 million in Q1 2025, and up 58.33% quarter-over-quarter from $9.4 million in Q4 2025.
Verano Holdings (VRNO) Capital Expenditures (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 6 years of Capital Expenditures data on file, last reported at $14.9 million in Q1 2026.
- Capital Expenditures for Q1 2026 came in at $14.9 million, up 7.74% year-over-year; the trailing twelve-month figure through Mar 2026 was $42.3 million (up 71.45% YoY), and the FY2025 annual result was $41.2 million, up 101.03% from the prior year.
- Capital Expenditures climbed to $14.9 million in Q1 2026 per VRNO's latest filing, from $9.4 million in the prior quarter.
- Over five years, Capital Expenditures peaked at $84.8 million in Q2 2022 and troughed at -$81.0 million in Q3 2022.
- A 5-year average of $5.2 million and a median of $9.4 million in 2025 frame the typical range for Capital Expenditures.
- The sharpest annual moves came in 2023 and 2024: Capital Expenditures plunged 16330.83% in 2023, then soared 468.04% in 2024.
- A 5-year view of Capital Expenditures shows it stood at $133000.0 in 2022, then sank by 16330.83% to -$21.6 million in 2023, then sank by 197.85% to -$64.3 million in 2024, then jumped by 114.67% to $9.4 million in 2025, then surged by 58.33% to $14.9 million in 2026.
- Business Quant data shows VRNO's Capital Expenditures at $14.9 million in Q1 2026, $9.4 million in Q4 2025, and $7.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 168.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 110.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 100.80 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 9.10 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 51.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 4.09 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 8.83 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 2.04 Mn |
| 10 | Verano Holdings | - | - | 98.98 Mn | 14.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.94 Mn |
| Mar 31, 2026 | 14.94 Mn |
| Dec 31, 2025 | 9.43 Mn |
| Dec 31, 2025 | 9.43 Mn |
| Sep 30, 2025 | 7.46 Mn |
| Sep 30, 2025 | 7.46 Mn |
| Jun 30, 2025 | 10.47 Mn |
| Jun 30, 2025 | 10.47 Mn |
| Mar 31, 2025 | 13.86 Mn |
| Mar 31, 2025 | 13.86 Mn |
| Dec 31, 2024 | -64.30 Mn |
| Dec 31, 2024 | -64.30 Mn |
| Sep 30, 2024 | 56.59 Mn |
| Sep 30, 2024 | 56.59 Mn |
| Jun 30, 2024 | 18.52 Mn |
| Jun 30, 2024 | 18.52 Mn |
| Mar 31, 2024 | 9.70 Mn |
| Mar 31, 2024 | 9.70 Mn |
| Dec 31, 2023 | -21.59 Mn |
| Dec 31, 2023 | -21.59 Mn |